GenprexOffering
Completed S-1 IPO NASDAQ: GNPX Lung Cancer Clinical Stage Gene Therapy
You are here
Page not found
Search results
Use Reg A+ To IPO, Raise Up To $75M Every Year For Subsidiaries Of Large Companies & Insider Liquidity- Interactive Indexed VideoBlog
insight to biologics, their cost of advertising, just the advertising cost. ... to refer to the questions that are in the comment section. Now, bear with me ...
Global Cancer TechnologyOffering
Invest in Remote-Controlled Drug Delivery
Advantages of using Reg A+ to raise up to $75 Mill per year of capital and provide liquidity (Short Video)Blog
of comments back from the SEC reduced the SEC seems to like Regulation A+, ...
Edoceo Devices- DEVELOPMENT PAGEOffering
Reardon is Professor and Jud and Pat Harper Chair of Chemical and Biological ... State University, including Cell and Molecular Biology and Biomedical ...
Edoceo DevicesOffering
Your Investment Helps Fight Against Deadly Bacteria & Viruses
Choosing The Optimum Valuation For Your Reg CF, Reg A+, Reg D, and Rule 144A® Capital Raise; Interactive Clickable VideoBlog
to the legal disclaimers in the, in the comments section about Manhattan street ... on those companies, so I'm not going to comment beyond that. Essentially ... their price. So I'm sorry. I can't comment on that. Why do I hear from ...
BiologxOffering
& Biology and a Bachelor of Science in Physiology from Indiana State ... & Biology from the University of Indiana, and an Associate of Science ...
Alternative Funding Vehicle for Medtech Startups: Raising Capital through Regulation A+- Interactive Clickable VideoBlog
that you have. Please feel free to post questions in the comment in the chat ... because I'm seeing the comments coming in order to make sure, you know, ...
CubCrafters Webinar: Q&A Session for Investors, Customers, and FansBlog
if you have any comments you would like to make in closing, I'd ... for the time today. Rod Turner: Brad, do you have any comments that you'd ...